연구동향 분석

Inhibition of lncRNA KCNQ1OT1 Improves Apoptosis and Chemotherapy Drug Response in Small Cell Lung Cancer by TGF-β1 Mediated Epithelial-to-Mesenchymal Transition

Deyu Li Qin Tong Yuane Lian Zhizhong Chen Yaru Zhu Weimei Huang Yang Wen Qiongyao Wang Shumei Liang Man Li Jianjing Zheng Zhenhua Liu Huanxin Liu Linlang Guo 년

논문상세정보
인용/피인용

' Inhibition of lncRNA KCNQ1OT1 Improves Apoptosis and Chemotherapy Drug Response in Small Cell Lung Cancer by TGF-β1 Mediated Epithelial-to-Mesenchymal Transition' 의 참고문헌

  • lncRNA KCNQ1OT1enhances the chemoresistance of oxaliplatin in colon cancer by targeting the miR-34a/ATG4B pathway
    Li Y [2019]
  • Zoledronic acid overcomes chemoresistance by sensitizing cancer stem cells to apoptosis
    Rouhrazi H [2018]
  • Unravelling the biology of SCLC : implications for therapy
    Sabari JK [2017]
  • The role of non-coding RNAs in oncology
    Slack FJ [2019]
  • The LINC01138drives malignancies via activating arginine methyltransferase 5 in hepatocellular carcinoma
    Li Z [2018]
  • Targeting epithelial-mesenchymal transition(EMT)to overcome drug resistance in cancer
    Du B [2016]
  • Targeting a long noncoding RNA in breast cancer
    Mendell JT [2016]
  • TGF-beta-induced epithelial to mesenchymal transition
    Xu J [2009]
  • Small-cell lung cancer : prognostic factors and changing treatment over 15 years
    Gaspar LE [2012]
  • Overexpression of long non-coding RNA KCNQ1OT1 is related to good prognosis via inhibiting cell proliferation in non-small cell lung cancer
    Sun X [2018]
  • M2 macrophages induce EMT through the TGF-beta/Smad2 signaling pathway
    Zhu L [2017]
  • Long noncoding RNA-HOTAIR affects chemoresistance by regulating HOXA1 methylation in small cell lung cancer cells
    Fang S [2016]
  • Long noncoding RNA GMAN, up-regulated in gastric cancer tissues, is associated with metastasis in patients and promotes translation of ephrin A1 by competitively binding GMAN-AS
    Zhuo W [2019]
  • Long non-coding RNA KCNQ1OT1 modulates oxaliplatin resistance in hepatocellular carcinoma through miR-7-5p/ABCC1 axis
    Hu H [2018]
  • Long non-coding RNA HOTTIP promotes BCL-2 expression and induces chemoresistance in small cell lung cancer by sponging miR-216a
    Sun Y [2018]
  • LncRNA KCNQ1OT1 is overexpressed in non-small cell lung cancer and its expression level is related to clinicopathology
    Zheng L [2019]
  • LncRNA KCNQ1OT1 enhanced the methotrexate resistance of colorectal cancer cells by regulating miR760/PPP1R1B via the cAMP signalling pathway
    Xian D [2019]
  • Linc00173 promotes chemoresistance and progression of small cell lung cancer by sponging miR-218 to regulate Etk expression
    Zeng F [2020]
  • KCNQ1OT1 promotes ovarian cancer progression via modulating MIR-142-5p/CAPN10 axis
    Liu H [2020]
  • KCNQ1OT1 promotes melanoma growth and metastasis
    Guo B [2018]
  • KCNQ1OT1 aggravates cell proliferation and migration in bladder cancer through modulating miR-145-5p/PCBP2 axis
    Wang J [2019]
  • Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010 : a systematic analysis for the Global Burden of Disease Study 2010
    Lozano R [2012]
  • Effects of metformin and phenformin on apoptosis and epithelial-mesenchymal transition in chemoresistant rectal cancer
    Park JH [2019]
  • Effects of LncRNA KCNQ1OT1 on proliferation and migration of ovarian cancer cells by Wnt/beta-catenin
    Luo ZP [2019]
  • Dysregulation of KCNQ1OT1 promotes cholangiocarcinoma progression via miR140-5p/SOX4 axis
    Sun H [2018]
  • Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer(CONVERT) : an open-label, phase 3, randomised, superiority trial
  • Cellular RNA surveillance in health and disease
    Wolin SL [2019]
  • Cancer therapy due to apoptosis : galectin-9
    Fujita K [2017]
  • Cancer incidence and mortality worldwide : sources, methods and major patterns in GLOBOCAN 2012
    Ferlay J [2015]
  • A long noncoding RNA HOTTIP expression is associated with disease progression and predicts outcome in small cell lung cancer patients
    Sun Y [2017]